Aevi Genomic Medicine to Host KOL Breakfast to Discuss Diagnosis and Treatment Paradigms in ADHD
Aevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business Update
Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial
Leaders in genetic science and commercial drug development
Discover the future of novel genetic therapies currently being researched by Aevi Genomic Medicine.
Presentations, information, and news